Dosage and protocol evidence
Each card states what the quantities are based on. A third-party or animal schedule is not a validated human dose.
Subcutaneous study doses began at 0.01 mg/kg and escalated on alternating study days
Only five active injections were given in a tiny monitored experiment; this cannot establish a routine protocol.
View sourceTwo monitored subcutaneous administrations of 0.025 mg/kg in a crossover study
This experiment measured erectile response over six hours and does not establish chronic or cosmetic use.
View source250 mcg daily in week 1, 500 mcg in week 2, 750 mcg in week 3 and 1 mg daily in weeks 4-8; the guide then describes 0.5-1 mg once or twice weekly
This escalation is a community convention, not a validated tanning regimen. It must remain separate from the tiny weight-based phase 1 experiments above.
View sourceEvidence summary
An unapproved cyclic melanocortin analogue with very small early human studies. The published schedules are phase 1 experiments, not a validated tanning protocol.
Protocol basis
The only directly matched human protocols are small, short, monitored experiments from the 1990s and 2000. They support an early-human tag but not a general-use schedule.
What remains uncertain
There is no authorised vial, validated long-term regimen or adequate evidence for cosmetic self-administration.